Pages that link to "Q39410429"
Jump to navigation
Jump to search
The following pages link to Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea (Q39410429):
Displaying 20 items.
- Symptom management in the older adult: 2015 update (Q30374202) (← links)
- The imperative for hospital-based palliative care: patient, institutional, and societal benefits (Q33944925) (← links)
- Symptom Management in Metastatic Breast Cancer (Q35584763) (← links)
- Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review (Q35829152) (← links)
- Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany (Q36431786) (← links)
- Clinical pearls in palliative medicine 2012. (Q36523445) (← links)
- Pain management, supportive and palliative care in patients with renal cell carcinoma (Q36794824) (← links)
- Control and sensation of breathing during cycling exercise in hypoxia under naloxone: a randomised controlled crossover trial (Q37008454) (← links)
- Gaps in the Evidence Base of Opioids for Refractory Breathlessness. A Future Work Plan? (Q37979552) (← links)
- Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia (Q38153817) (← links)
- Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease (Q38873648) (← links)
- Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea (Q39094041) (← links)
- Nebulized opioids for the palliation of dyspnea in terminally ill patients (Q39153141) (← links)
- Nebulized Fentanyl for Dyspnea in a Hospice Patient with True Allergy to Morphine and Hydromorphone (Q39158528) (← links)
- Pharmacological treatment of refractory breathlessness (Q43061646) (← links)
- Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function (Q43111565) (← links)
- Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care--overview and case report (Q43164296) (← links)
- A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer (Q43538185) (← links)
- Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient (Q45208284) (← links)
- Inhaled Fentanyl Citrate Improves Exercise Endurance During High-Intensity Constant Work Rate Cycle Exercise in Chronic Obstructive Pulmonary Disease (Q48203852) (← links)